These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29667356)

  • 21. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
    Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
    PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
    Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).
    Richards M; Di Somma S; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Clopton P; Filippatos GS; Anand I; Ng L; Daniels LB; Neath SX; Shah K; Christenson R; Hartmann O; Anker SD; Maisel A
    JACC Heart Fail; 2013 Jun; 1(3):192-9. PubMed ID: 24621869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
    Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
    Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Stages of Obesity-related Heart Failure Are Associated with Natriuretic Peptide Deficiency and an Overall Lack of Neurohormonal Activation: The Copenhagen Heart Failure Risk Study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Kamstrup PR; Faber J; Køber L; Schou M
    Glob Heart; 2020 Mar; 15(1):25. PubMed ID: 32489798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies.
    Luers C; Sutcliffe A; Binder L; Irle S; Pieske B
    Clin Biochem; 2013 Aug; 46(12):1013-1019. PubMed ID: 23542086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
    Kube J; Ebner N; Jankowska EA; Rozentryt P; Cicoira M; Filippatos GS; Ponikowski P; Doehner W; Anker SD; von Haehling S
    Int J Cardiol; 2016 Sep; 219():84-91. PubMed ID: 27288971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effect of obesity on N-terminal pro-B-type natriuretic peptide cut-off concentrations for the diagnosis of acute heart failure.
    Kozhuharov N; Martin J; Wussler D; Lopez-Ayala P; Belkin M; Strebel I; Flores D; Diebold M; Shrestha S; Nowak A; Gualandro DM; Michou E; Zimmermann T; Rentsch K; von Eckardstein A; Keller DI; Breidthardt T; Mueller C;
    Eur J Heart Fail; 2022 Sep; 24(9):1545-1554. PubMed ID: 35851710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
    Porcel JM; Bielsa S; Morales-Rull JL; Civit C; Cao G; Light RW; Esquerda A
    Respirology; 2013 Apr; 18(3):540-5. PubMed ID: 23278975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Randomized Control Trial Using a Validated Prediction Model for Diagnosing Acute Heart Failure in Undifferentiated Dyspneic Emergency Department Patients-Results of the GASP4Ar Study.
    Steinhart BD; Levy P; Vandenberghe H; Moe G; Yan AT; Cohen A; Thorpe KE; McGowan M; Mazer CD
    J Card Fail; 2017 Feb; 23(2):145-152. PubMed ID: 27565045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.
    Gegenhuber A; Mueller T; Dieplinger B; Poelz W; Pacher R; Haltmayer M
    Clin Chim Acta; 2006 Aug; 370(1-2):174-9. PubMed ID: 16600203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal Variations in Natriuretic Peptide Levels: Clinical Implications for the Diagnosis of Acute Heart Failure.
    Breidthardt T; van Doorn WPTM; van der Linden N; Diebold M; Wussler D; Danier I; Zimmermann T; Shrestha S; Kozhuharov N; Belkin M; Porta C; Strebel I; Michou E; Gualandro DM; Nowak A; Meex SJR; Mueller C
    Circ Heart Fail; 2022 Jun; 15(6):e009165. PubMed ID: 35670217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosing Acute Heart Failure in the Emergency Department: A Systematic Review and Meta-analysis.
    Martindale JL; Wakai A; Collins SP; Levy PD; Diercks D; Hiestand BC; Fermann GJ; deSouza I; Sinert R
    Acad Emerg Med; 2016 Mar; 23(3):223-42. PubMed ID: 26910112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.
    Stanton E; Hansen M; Wijeysundera HC; Kupchak P; Hall C; Rouleau JL;
    Eur J Heart Fail; 2005 Jun; 7(4):557-65. PubMed ID: 15921795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
    Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.
    Mueller C; McDonald K; de Boer RA; Maisel A; Cleland JGF; Kozhuharov N; Coats AJS; Metra M; Mebazaa A; Ruschitzka F; Lainscak M; Filippatos G; Seferovic PM; Meijers WC; Bayes-Genis A; Mueller T; Richards M; Januzzi JL;
    Eur J Heart Fail; 2019 Jun; 21(6):715-731. PubMed ID: 31222929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.
    deFilippi CR; Seliger SL; Maynard S; Christenson RH
    Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.